Estimate Recalculated Apr 2, 2025 09:11PM EST
Graham K Cooper has an estimated net worth of $7.15 Million. This is based on reported shares across multiple companies, which include Panacea Acquisition Corp, Orexigen Therapeutics, Inc., Receptos, Inc., Kezar Life Sciences, Inc., GERON CORP, Celladon Corp, Applied Molecular Transport Inc., Beam Therapeutics Inc., Unity Biotechnology, Inc., and ASSEMBLY BIOSCIENCES, INC..
Graham K Cooper's CIK is 0001396943
2021 was Graham K Cooper's most active year for acquiring shares with 7 total transactions. Graham K Cooper's most active month to acquire stocks was the month of May. 2009 was Graham K Cooper's most active year for disposing of shares, totalling 42 transactions. Graham K Cooper's most active month to dispose stocks was the month of November. 2014 saw Graham K Cooper paying a total of $255,000.00 for 96,945 shares, this is the most they've acquired in one year. In 2015 Graham K Cooper cashed out on 194,110 shares for a total of $39,632,441.55, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!